The Food and Drug Administration rejected a bid from Elon Musk's human brain chips startup Neuralink to start human trials, according to Reuters.
Share:
More In Science
Elon Musk's Neuralink Is Seeking Partners for Human Testing of Brain Implants
Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report.
Minnesota Nuclear Plant Shuts Down for Leak; Residents Worry
A Minnesota utility began shutting down a nuclear power plant near Minneapolis on Friday after discovering water containing a low level of radioactive material was leaking from a pipe for the second time. While the utility and health officials say it is not dangerous, the issue has prompted concerns among nearby residents and raised questions about aging pipelines.
Good2Know: Philly Monitoring Water After Chemical Spill
The City of Philadelphia is closely monitoring its drinking water following a chemical spill that occurred on Friday night.
Survey: Mental Health Issues Increasingly Impact College Students Decision to Drop Out
Survey: Mental Health Issues Increasingly Impact College Students Decision to Drop Out
CDC, FDA Report More Deaths, Vision Loss Linked to Recalled Eye Drops
At least three people have died and 65 others have suffered vision issues stemming from contaminated eye drops.
FDA OKs Expanded Use of Cholesterol Drug for Children
The Food and Drug Administration approved the expanded use of Regeneron's cholesterol drug in children aged 5-11.
Grindr Looks to Distribute 1 Million Free HIV Test Kits in New Initiative
The LGBTQ+ dating app Grindr is doing its part to snuff out the HIV epidemic by offering free at-home test kits to users.
FDA Approves Regeneron Cholesterol Drug Use For Children
The Food and Drug Administration expanded its approval of Regeneron's cholesterol drug for children.
FDA Expands Use Of Regeneron's Children Cholesterol Drug Evkeeza
The FDA has approved the expanded use of Regeneron's drug Evkeeza in children to treat a rare disease that causes high cholesterol.
